Neck Carcinoma — Trials

Neck Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,419 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 464
Recruiting: 240
Ph III recruiting: 63
Growth YoY: +3.1%
Industry share: 9%
Top sponsor: Sun Yat-sen University
Termination share: 31.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (128)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06490341	GP Combined With Nimotuzumab and Sintilimab as Induction Therapy for Nasopharyngeal Carcinoma	not yet recruiting	Phase 2	20	Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER	0	Jul 8, 2024	clinicaltrials
NCT06331845	Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma	not yet recruiting	Phase 2	39	Fujian Cancer HospitalOTHER_GOV	0	Mar 26, 2024